Skip to main content

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Maria Teresa Mateu Peláez

Institutions of which they are part

Predoctoral researcher
Headache and Neurological Pain
Vall Hebron Institut de Recerca

Related news

The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease.

Funding has been obtained for 43 projects under the calls for Health R&D&I Projects, Health Technology Development, and Independent Clinical Research

Two international studies led by Vall d'Hebron recommend early administration of specific drugs to prevent migraine to achieve a better response to therapy.

Related professionals

Anna Martí Boltaina

Anna Martí Boltaina

Research technician
Cardiovascular Diseases
Read more
Elisabet Miro Casas

Elisabet Miro Casas

Research technician
Cardiovascular Diseases
Read more
Carlos Jose Sierra Vazquez

Carlos Jose Sierra Vazquez

Multidisciplinary Nursing Research Group
Read more
Edurne Ruiz Marti

Edurne Ruiz Marti

Infectious Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.